Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Spinery® A Novel Radio-Frequency Tumor Ablation Device for Spine Metastatic Tumors

NCT05467540 is registered in ClinicalTrials.gov with Axon srl as lead sponsor.

NCT NCT05467540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05467540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Spinery® A Novel Radio-Frequency Tumor Ablation Device for Spine Metastatic Tumors
Lead sponsor
Axon srl
Phase
Not applicable
Overall status
Completed
Start date
July 11, 2022
Completion date
November 30, 2024
Enrollment
52 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

vertebral metastasis